A study recently published in Clinical Infectious Diseases found that substantial gaps exist between CDC recommendations for STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngeal exposure sites that can harbor asymptomatic infections and for men who have sex with men (MSM) in Southeast states where the STI burden is substantial. Among PrEP users in the study, 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab, or pharyngeal swab, respectively, during PrEP care.
Read the findings on PubMed.
